Dalton, Greiner, Hartman, Maher & Co’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
Other funds holding EHC
JP
Dalton, Greiner, Hartman, Maher & Co's EHC Position: Q2 2021 in Review
Dalton, Greiner, Hartman, Maher & Co sold out of Encompass Health (EHC) in Q2 2021, closing a stake of 20,112 shares — an estimated $1.31M sold.
Dalton, Greiner, Hartman, Maher & Co first reported a position in EHC in Q3 2017 and held it in 15 quarters. The position peaked at $24.6M in Q2 2018. 414 funds tracked by Wall St. Rank hold EHC as of Q2 2021.
- Dalton, Greiner, Hartman, Maher & Co reported no remaining Encompass Health position as of Q2 2021 after selling out during the quarter.
- Dalton, Greiner, Hartman, Maher & Co sold 20,112 Encompass Health shares in Q2 2021, an estimated $1.31M.
- Dalton, Greiner, Hartman, Maher & Co first reported a position in Encompass Health in Q3 2017 and held it in 15 quarters.
- Dalton, Greiner, Hartman, Maher & Co's Encompass Health position peaked at $24.6M in Q2 2018.
- 414 funds tracked by Wall St. Rank held Encompass Health as of Q2 2021.
Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.